共 50 条
- [31] SERIOUS ADVERSE EVENTS WITH LOW-DOSE, LONG-TERM CORTICOSTEROID-THERAPY IN RHEUMATOID-ARTHRITIS - REPLY AMERICAN JOURNAL OF MEDICINE, 1995, 99 (06): : 693 - 694
- [32] LOW-DOSE LONG-TERM CORTICOSTEROID-THERAPY IN RHEUMATOID-ARTHRITIS - AN ANALYSIS OF SERIOUS ADVERSE EVENTS AMERICAN JOURNAL OF MEDICINE, 1994, 96 (02): : 115 - 123
- [33] INTERFERON-GAMMA IN THE THERAPY OF RHEUMATOID-ARTHRITIS - LONG-TERM THERAPY IN PRACTICE ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1989, 39-2 (07): : 819 - 822
- [35] MORBIDITY ASSOCIATED WITH LONG-TERM METHOTREXATE THERAPY IN JUVENILE RHEUMATOID-ARTHRITIS JOURNAL OF PEDIATRICS, 1992, 120 (03): : 468 - 473
- [36] THE SAFETY AND EFFICACY OF THE USE OF METHOTREXATE IN LONG-TERM THERAPY FOR RHEUMATOID-ARTHRITIS ARTHRITIS AND RHEUMATISM, 1986, 29 (07): : 822 - 831
- [37] EFFECT OF LONG-TERM THERAPY WITH TRANSFER-FACTOR IN RHEUMATOID-ARTHRITIS REVUE ROUMAINE DE MEDECINE-MEDECINE INTERNE, 1985, 23 (02): : 135 - 140
- [38] FLURBIPROFEN IN RHEUMATOID-ARTHRITIS - A LONG-TERM EXPERIENCE CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1983, 33 (03): : 423 - 427